0000-00-00 |
|
|
|
External link to document |
2019-09-06 |
1 |
Complaint |
076 patent"),
9,700,542 ("the '542 patent"), and 10,213,415 ("the '415 patent…356
patent, the '158 patent, the '011 patent, the '709 patent, the '325 patent, the…356 patent, the '158 patent, the '011 patent, the '709 patent, the '325 patent, the…356 patent, the '158 patent, the '011 patent, the '709 patent, the '325 patent, the…The '356 patent, the '158 patent, the
'011 patent, the '709 patent, the '325 |
External link to document |
2021-08-09 |
72 |
Stipulation-General (See Motion List for Stipulation to Extend Time) |
8,609,709, 8,772,325, 9,205,076, 9,700,542, 10,213,415 by Allergan Holdings Unlimited Company, Allergan Pharmaceuticals… STIPULATION Concerning Infringement of U.S. Patent Nos. 7,741,356, 7,786,158, 8,344,011, 8,609,709…2019
9 February 2022
1:19-cv-01674
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2021-08-09 |
73 |
Order |
of U.S. Patent Nos. 7,741,356; 7,786,158; 8,344,011; 8,609,709; 8,722,325; 9,205,542; 10,213,415. Signed…2019
9 February 2022
1:19-cv-01674
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |